CompletedNCT00244413
Characteristics of Nondystrophic Myotonias
Studying Thomsen and Becker disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Richard Barohn, MD
- Principal Investigator
- Richard Barohn, MDUniversity of Kansas Medical Center
- Enrollment
- 94 enrolled
- Eligibility
- 6 years · All sexes
- Timeline
- 2006 – 2012
Study locations (6)
- University of Kansas Medical Center, Department of Neurology, Kansas City, Kansas, United States
- Brigham & Women's Hospital, Department of Neurology, Boston, Massachusetts, United States
- University of Rochester School of Medicine and Dentistry, Department of Neurology, Rochester, New York, United States
- University of Texas Southwestern Medical Center, Dallas, Texas, United States
- London Health Sciences Centre, University Hospital, London, Ontario, Canada
- Center for Neuromuscular Disease, Institute of Neurology and National Hospital for Neurology, London, United Kingdom
Collaborators
Office of Rare Diseases (ORD) · Rare Diseases Clinical Research Network
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00244413 on ClinicalTrials.govOther trials for Thomsen and Becker disease
Additional recruiting or active studies for the same condition.